Request Demo
Last update 21 Nov 2024
HOB-047
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms + [2] |
Target |
Mechanism GPR40 agonists(Free fatty acid receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with HOB-047NCT06647550
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding, Phase 2 Study to Assess the Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
NCT05666128
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 2 Study to Assess the Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
100 Clinical Results associated with HOB-047
Login to view more data
100 Translational Medicine associated with HOB-047
Login to view more data
100 Patents (Medical) associated with HOB-047
Login to view more data
100 Deals associated with HOB-047
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 2 | KR | 17 Jun 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT05666128 (ADA2024) Manual  | Phase 2 | 112 | HD-6277 50mg | (anxbpxqaam) = nbqjelnhyu bpqshxtqnt (ufbfniksoq, -1.11 to -0.35) | Positive | 21 Jun 2024 | |
HD-6277 100mg | (anxbpxqaam) = tuzwplqefa bpqshxtqnt (ufbfniksoq, -1.21 to -0.50) | ||||||
Not Applicable | 20 | (hvpvftdmmz) = ruxcsevyla igemamadpe (hoyalejkqo ) View more | - | 01 Jun 2020 | |||
(hvpvftdmmz) = fzmiuuqdxf igemamadpe (hoyalejkqo ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free